Nebuliser therapy in childhood
Peter W Barry, Christopher O'Callaghan Jet and ultrasonic nebulisers continue to be of medications and this may reduce the deposition of the drug in the periphery of the lungs. The value in childhood. Nebulised therapy provides a portal of entry for systemic drug treatment effect of crying on aerosol deposition is not known. as well as for the direct treatment of respiratory diseases.
Work by Collis has focused attention on the total amount of nebulised drug inhaled by A number of problems arise in evaluating nebulised therapy in children including ana-young children. 6 He showed that the quantity of nebulised aerosol that may be inspired, intomical and physiological variations due to age, compliance, problems with drug delivery and cluding that deposited in the nose and upper airways, may be independent of the size of the drug delivery devices, and difficulty in knowing the dose received by the patient. Doses used child after six months of age (fig 1) . Young children with small tidal volumes will inhale have largely evolved empirically and delivery methods have been adapted from adult prac-pure aerosol from a nebuliser. As children grow their peak inspiratory flow exceeds the nebuliser tice. Nominal drug doses used for infants are often similar to those used in older children or output and they entrain surrounding air not containing aerosol. Thus, for a typical nebuadults. The purpose of this review is to describe differences between adults and children which liser, older children will inspire the same dose as adults once their inspiratory flow exceeds may be of importance for nebulised therapy, to discuss the clinical uses of nebulisers in nebuliser flow and the entire nebuliser output is inhaled. Only infants will inspire with a lower childhood, and to give practical guidelines for the choice and use of nebulisers.
flow than that of the nebuliser output, and only then will the dose received be affected by the child's size. The importance of this observation has been highlighted in relation to bronchoAnatomical and physiological differences provocation studies in infants and young chilbetween children and adults dren.
7
     Stick and colleagues 8 investigated airways Although most young children nose breath at responsiveness to histamine and concluded that rest, their mode of breathing during nebuinfants aged one month responded to a much lisation is unclear. Nasal breathing reduces lower concentration than did older children lung deposition of nebulised drugs in adults by (median 10 years). However, when they later about 50%.
1 Little is known of this in children. took into account the nebuliser gas flow in The upper airway in infants is larger with respect to body size than in adulthood. This, together with the absence of nasal hair in the preadolescent, may make nasal breathing less of a problem than might be expected. Nasal obstruction during upper respiratory tract obstruction may also affect lung deposition when the child is nose breathing.
Another problem with nasal breathing was highlighted in older children breathing through the mouthpiece of a spacer device, where therapeutic failures were attributed to inappropriate inhalation through the nose rather than the mouthpiece.
2 Inhalation training is necessary for all children prescribed a nebuliser.
  3 4
Deposition of nebulised drugs within the lung calculating the concentration of histamine in-in cystic fibrosis may be best delivered to the distal airways and alveoli. Clearly, different spired there was no difference in responsiveness. Thus, the apparent age related nebuliser systems are needed in each case. decline in airways responsiveness of children may be an artefact and there may be a need to correct agonist doses for patient size in such  Several models have been proposed to calculate studies.
Data from Salmon et al 9 suggested that up the deposition of particles within the respiratory tract of children. These make a number of to 1.5% of a dose of nebulised sodium cromoglycate will be deposited in the lungs of assumptions about breathing pattern and the structure of the upper and lower respiratory children aged 6-36 months. Assuming approximately 10% of a nebulised dose is de-tracts. Thomas 23 assumed nasal breathing at rest, estimated nasal dimensions from the posited in the lungs of an adult, the dose/kg body weight can be calculated. For example, a tracheal cross sectional area (assuming the infant nose to be a scaled down adult one), 70 kg adult will receive 0.14%/kg (10%/70) whereas, using Salmon's data, young children and made assumptions about age related tidal volume and respiratory rate. He predicted that will receive up to 0.15%/kg (1.5% in a 10 kg infant). This suggests that, although there may nasal deposition would rise with age so that 0.2% of particles of 2 m diameter would debe poor drug deposition in infant lungs, this is compensated for by their small size so that the posit in the nose at one month, rising to 37.8% at 10 years. Xu and Yu, 24 making different final dose/kg body weight reaching the lungs may be very similar to that of an adult.
assumptions, predicted the opposite trend with oral deposition and estimated that 6% of particles of 2 m diameter would deposit in the mouth at one month, falling to 0% at 10 years.   Nebulised aerosols are unevenly distributed To improve these models, age related measurements of upper airways dimensions, the with more central deposition in adult subjects with bronchoconstriction than in those with relative amounts of nasal and oral breathing at different ages, and the effect of airways normal lung function.
10 11 Similar results have been found in children (discussed below).
12-15 obstruction on particle deposition in the upper airways and lungs are needed. The lower airways of infants are narrow and, as airways resistance is inversely related to the There have been few deposition studies of nebulised aerosols in children. Alderson et al 12 fourth power of the airway radius, a small amount of airway narrowing due to broncho-used a DeVilbiss 900 ultrasonic nebuliser and face mask to study radiolabelled aerosols in spasm, inflammation or secretions may result in a considerable increase in resistance 11 children with cystic fibrosis aged from 18 months to 17 years and found large extrawhich encourages central airways deposition. This suggests that the optimum particle size thoracic deposition in the younger children and increased lung deposition with age. Those for inhaled therapy in children is smaller than adults, and smaller still for children with bron-with normal ventilation scans had uniform deposition of labelled aerosol, whereas those with choconstriction. Producing aerosols with smaller droplets will mean alterations to nebuliser areas of reduced ventilation had corresponding areas of reduced deposition. The mode of design and lengthening nebulisation timesissues which are discussed in the paper on pp inhalation was not noted, but nose breathing by the younger children may explain the differ-S31-44. However, it may not be practical to nebulise some medications in small enough ences.
O'Doherty and colleagues 13 found total lung particles to produce a therapeutic effect. 16 deposition of pentamidine to be similar (2.5% of the nominal dose) in a group of eight children aged 8-13 years inhaling technetium-99m  Nebulised 2 agonists block the broncho-labelled albumin from a Respirgard nebuliser and mouthpiece to a group of adults. There constricting activity of histamine 17 and nebulised water, 18 suggesting that 2 receptors was no relationship between age and total deposition, but the children had more central are present within the infant lung. However, several clinical studies have failed to show a deposition than the adults.
Conversely, Mukhopadhyay and colleagues 14 response to nebulised bronchodilators in infancy. Although this may be because the failed to show a significant relationship between indices of pulmonary damage and total lung underlying cause is mucosal oedema and inflammation rather than bronchoconstriction, deposition of radiolabelled tobramycin inhaled via a mouthpiece in a group of 27 children and failure to deliver the drug in sufficient quantity to the airway may also be important. found a median lung deposition of 6% in eight young children due to difficulty in measuring baseline respiratory function and controlling children with cystic fibrosis aged 6-18 years during mouth breathing. Nose breathing in the inhalation in an often uncooperative age group.
The administration of radiolabelled drugs to same group reduced lung deposition to 2.7%, while the median deposition in infants aged young children and infants has tended to be restricted to those with serious underlying res-0.3-1.4 years, who breathed nasally during quiet sleep, was 1.3%. piratory problems. Although the total radioactive dose in these studies is small, impaction theory and work with other aerosols suggest that high central deposition may occur and Measuring aerosol delivery There are a number of problems in measuring "hot spots" of deposition may be found over a small area at airway bifurcations. 25 The impact the aerosol that is delivered to infants and group.bmj.com on April 5, 2017 -Published by http://thorax.bmj.com/ Downloaded from of uneven deposition and hot spots on the acute phase of treatment the wheezing and respiratory rate increased. Surprisingly few calculated risk of radioisotope administration has received little attention. 26 toxic effects occurred. These included transient unifocal premature ventricular contractions, Lung deposition may also be estimated using a pharmacokinetic approach 27 28 (see also the hyperglycaemia, muscle cramps, and tremor.
Transiently raised creatine phosphokinase review on pp S31-44). levels may occur in children receiving high dose continuous salbutamol 37 but its significance is not clear. Moler 38 compared plasma conClinical use of nebulisers in childhood  centrations and cardiac side effects of terbutaline in 16 children with "stable asthma" Nebulisers are used most commonly in acute severe asthma and in children too young to use given 16 mg terbutaline either continuously or as four doses of 4 mg over 20 minutes in a other devices. There is considerable variation in nebuliser usage in Europe with a more than randomised double blind trial. Continuous nebulisation produced similar plasma coneight fold difference between countries in the number of physicians prescribing nebulised centrations and cardiovascular effects to intermittent therapy. Increased creatine phosphosteroids to children. 29 Nebulisers are bulky, expensive, and inconvenient and, where pos-kinase levels were not seen.
Side effects may be dose related. Portnoy et sible, metered dose inhalers with spacer devices or dry powder inhalers are the preferred method al 35 have suggested that continuous terbutaline should be given at a dose of 1-3 mg/hour since of drug delivery. 30 this dose is efficacious and causes few side effects. Singh and Kumar 39 have confirmed these findings with salbutamol at a dose of
Status asthmaticus
It is important to use oxygen to drive nebulisers 0.15 mg/kg/hour.
In a prospective randomised study Papo 40 wherever possible. Nebulised salbutamol is beneficial in the treatment of severe acute asthma treated 17 children with either continuous or intermittently nebulised salbutamol (0.3 mg/ in adults prior to admission to hospital, 31 and high dose inhaled 2 agonists given by kg/hour or 0.3 mg/kg over 20 minutes every hour). As judged by the clinical score and blood nebuliser or metered dose inhaler and spacer (see below) are recommended in the immediate gas values, the children treated continuously improved faster and spent less time in hospital treatment of severe asthma (fig 2) .
A recent advance in the management of acute than those receiving intermittent treatment. No side effects were seen. childhood asthma has been the use of frequent and repeated nebulisation of 2 agonists. FreThe International Paediatric Asthma Consensus Group 41 have suggested that inhaled 2 quent nebulisation (every 20 minutes) of a 2 agonist led to a smoother increase in FEV 1 and agonists can be used in far higher doses and for longer periods than have hitherto been an earlier and better maintained peak response than hourly treatment. 32 A dose of 0.15 mg/kg recommended, including continuous administration of full strength respirator solutions salbutamol (to a maximum of 5 mg) given every 20 minutes appears to be more effective than of salbutamol and terbutaline, although only in a hospital intensive care unit. Typical equiplower doses. 33 Continuous nebulisation in non-intubated ment used for the continuous administration of nebulised treatment is shown in fig 3. children with severe asthma in intensive care is becoming more common. Moler et al 34 Many children under the age of 18 months recover spontaneously from wheeze without studied 19 children and found continuous nebulisation of terbutaline (4 mg/hour) to be treatment. Indeed, under the age of 12 months an argument could be made for observing ineffective in improving clinical scores and decreasing arterial carbon dioxide tension fants with mild to moderate wheeze, especially as treatment with nebulised bronchodilators (Pa 2 ). No significant toxicity was recorded during treatment lasting up to 37 hours. Port-may be associated with transient drops in oxygen saturation and short term paradoxical noy et al 35 found that 12 patients treated with continuous nebulised terbutaline (1-12 mg/ bronchoconstriction.
19 21 In practice a therapeutic trial is usually undertaken. Nebulised hour for 1-24 hours) showed improvement in gas exchange and respiratory rate within an salbutamol, given in two doses one hour apart, relieved clinical signs of respiratory distress in average of eight hours. No significant toxicity was noted and all 12 were discharged from the wheezy children less than two years of age more effectively than placebo, 42 and nebulised intensive care unit within 24 hours. In a further 26 children 36 with severe exacerbations of ipratropium bromide was effective in 40% of wheezy infants admitted to hospital. 43 asthma unresponsive to systemic theophylline, methylprednisolone and intermittent 2 agonist Nebulisers are sometimes recommended for home treatment. In one survey 20% of parents inhalation, continuously nebulised terbutaline administered at doses of 1-12 mg/hour for a gave a second dose of nebulised bronchodilator rather than seeking help when their child did mean duration of 7-8 hours (range 1-24) caused clinical scores to improve rapidly and not improve. 44 Clear written and verbal instructions need to be given. Mild attacks charall patients showed marked improvement in pH and Pa 2 during the first two hours. Im-acterised by the absence of severe or life threatening features (fig 2) may be treated with provement in oxygenation was more variable and tended to be delayed. If nebulisation was nebulised bronchodilator therapy every 4-6 hours providing the child responds well to each interrupted even for a few minutes during the spacer, to 10 children with asthma. 48 All three methods of drug delivery produced significant changes in lung function compared with placebo, but the increase in FEV 1 , FVC, and peak flow were greatest with the metered dose inhaler and spacer.
The use of spacer devices with face mask attachments -for example, the Aerochamber, the Volumatic with Laerdal face mask, the Nebuhaler with McCarthy mask, and the Babyhaler -are becoming increasingly popular. Treatment of asthmatic infants with inhaled steroids via such devices has been particularly successful in a group that is otherwise difficult to treat. 49 50 Less drug is deposited in the mouth and oropharynx than with nebulisation and treatment time is shorter.
In acute severe asthma: randomised trials [51] [52] [53] [54] [55] [56] [57] [58] comparing nebulisers and metered dose inhalers in the treatment of acute severe childhood asthma are outlined in treatment of acute severe asthma 45 concluded that there was no significant difference between the two delivery methods. The minority of studies that claim nebulisers to be superior dose and there is a steady improvement. A "good response" may include a reduction in have compared the bronchodilator response in acute exacerbations using lower doses of 2 dyspnoea and in the use of accessory muscles of respiration, a decrease in respiratory rate and agonists from metered dose inhalers than from nebulisers or, where numerical dose equiaudible wheeze, and a resumption of normal activities such as playing and feeding. If the valence has been maintained, 59 the spacer has been used in such a way that most of the dose response is poor with worsening of the above features, or lasts less than four hours, or if the administered is not available for inhalation.
60
The use of a spacer and metered dose inhaler child is becoming worse, the family doctor should be consulted with regard to possible is cheaper than a nebuliser. 61 Newhouse has commented 62 that in several studies aerosols hospital admission and oral corticosteroid therapy (prednisolone 2 mg/kg). Prophylaxis generated by metered dose inhalers have been 50-75% less expensive than equivalent nebushould be considered in children requiring nebulised bronchodilator therapy on a regular liser therapy, although this estimate includes the cost of respiratory therapists who are not basis. 30 Several studies have shown that a 2 agonist generally used in UK hospitals. Spacers and metered dose inhalers may easily be used in delivered by a metered dose inhaler and large volume spacer device is as effective as a nebu-acute asthma and should be administered by giving one puff every few seconds until imliser for rapidly achieving maximum possible bronchodilation in severe exacerbations of provement occurs (up to 20 puffs). 30 asthma.
45
Prophylaxis of asthma Sodium cromoglycate remains a safe proNebulisers compared with metered dose inhalers In chronic asthma: terbutaline delivered by a phylactic treatment for childhood asthma. 63 64 It reduces symptoms when given four times a metered dose inhaler and Nebuhaler spacer provided similar clinical benefit to nebulised day, 65 although it may not do so in younger children when given three times a day. 66 67 Soterbutaline in the long term management of children and adults with stable airflow ob-dium cromoglycate compares favourably with oral theophylline in controlling symptoms and struction. 46 A dose response study of inhaled terbutaline administered via a large volume the absence of side effects. 68 If asthma symptoms are not controlled by sodium cromospacer or nebuliser in asthmatic children also found that they were equivalent in children glycate then inhaled steroids are usually considered. The nebuliser suspension of who were not in acute respiratory difficulty. 47 In a randomised double blind crossover study beclomethasone dipropionate has been discontinued. Clinical trials using this nebulised fenoterol was given by nebuliser or by metered dose inhaler, with or without a large volume formulation showed little benefit 69 as only a shorter treatment times in ER R = randomised; NB = not blinded; DB = double blind; NEB = nebuliser; MDI = metered dose inhaler; PEF = peak expiratory flow; FEV 1 = forced expiratory volume in one second; FVC = forced vital capacity; SaO 2 = oxygen saturation; ER = emergency room; NEB = MDI = no difference in outcome between nebuliser and metered dose inhaler groups; NEB < MDI = outcome measures significantly better in the metered dose inhaler group.
small amount of drug exited nebulisers in part-humidification device. Some studies have shown an effect of the size of the endotracheal icles small enough to enter the lungs. 16 Budesonide suspension appears to give a thera-tube on drug delivery in vitro, 77 while others have not. 78 79 There is considerable variation in peutic dose of drug contained in respirable particles 70 71 and may reduce the need for oral the amount of drug delivered from different nebulisers 80 81 and from the same nebuliser to therapy in adults 72 and children 73 with severe chronic asthma. Nebulised budesonide re-different patients. 82 83 Evaluating five different nebulisers in a neonatal circuit with a pressure duced the need for other maintenance treatment in 47 of 56 infants and preschool children limited ventilator and 3.5 mm endotracheal tube without additional humidification, Camwith severe chronic asthma in one study 74 but not in another. 75 eron et al 80 found that deposition of an aerosol of aminophylline onto a filter varied by a factor The use of a mouthpiece improves lung deposition and reduces deposition on the face. of 10. Furthermore, there were considerable differences between the ability of the different However, young children may not use the mouthpiece properly, inhaling through the nebulisers to deliver a suspension. In vitro nebulisers producing small, sub-micronic partnose, blocking the mouthpiece with the tongue, or simply blowing through the mouthpiece. icles appear to deliver more drug, 77 but in clinical practice many of these tiny particles The best delivery method should be individually determined. If a face mask is used may be exhaled and, when suspensions are being nebulised, the aerosol produced may not for nebulised corticosteroids the eyes and face should be washed after each treatment and a contain any drug particles.
Animal and in vitro studies have shown that drink given. Holes in the mask should be covered if the drugs in the aerosol are po-lung deposition of aerosol may be improved by increasing the volume fill, 81 84 increasing the tentially harmful to the eyes. If a child complains of a sore throat or is reluctant to feed, proportion of the respiratory cycle spent in inhalation, 81 84 and increasing tidal volume and oral candidiasis should be looked for.
aerosol residence time within the lung. 85 Humidification during jet nebulisation is provided by the nebuliser and additional humidification      Most non-elective admissions to intensive care decreases lung deposition. 77 78 When nebulisers are used as the source of driving gas in ventilator are related to respiratory disease or failure, 76 making the inhaled route particularly logical circuits, significant changes may need to be made to the ventilator settings. Aerosol flow in for treatment. Compared with instillation into the trachea, nebulisation results in a much the ventilator circuit may lead to excessive drug deposition on ventilator parts leading to valve more homogenous distribution of drug in the lung. There is, however, a paucity of in-malfunction. 85 The use of in line filters on the expiratory limb is recommended. formation concerning nebuliser use in paediatric intensive care.
Nebulisers may run continuously during ventilation or may be phased to operate only during inspiration. This, however, does not necessarily improve drug delivery, presumably Mechanical ventilation Nebulised aerosol therapy during mechanical because there is a delay between nebuliser actuation and aerosol production which occurs toventilation, also discussed by O'Doherty and Thomas on pp S56-59, is affected by the type wards the end of the inspiratory phase. 82 With continuous nebulisation considerable amounts of nebuliser, the volume fill, the treatment time, the inspiratory time, and the presence of a of aerosol tend to be expelled with the waste group.bmj.com on April 5, 2017 -Published by http://thorax.bmj.com/ Downloaded from gases or are deposited in the ventilator tubing.
Grigg et al subsequently studied the delivery of budesonide from a spacer and metered dose Lung deposition of nebulised aerosol is 1-5% of the initial dose in most studies. Although inhaler in a ventilator circuit using the same test lung methodology 94 and reported an enthis appears small, it is in fact extremely large when expressed per kg body weight. One study couragingly high percentage of drug delivery (14.2% of the dose). These results imply that in adults 83 in which all the factors outlined above were optimal delivered over 15% of the different drugs may behave differently within spacers and underline the need for devices dose of radiolabelled albumin placed in a nebuliser. Like some of the other studies quoted to be evaluated with each different drug and formulation. above, delivery of aerosol was through a tracheostomy tube. It remains to be seen if these high levels of drug delivery can be repeated in children using nasotracheal or orotracheal  tubes and different nebulisers and types of Several lung disorders in the newborn may be ventilator.
amenable to inhaled therapy. 2 agonists and Several papers have described the in vitro anticholinergic agents are effective in ventilated administration of aerosols to the mechanically and spontaneously breathing infants. [95] [96] [97] [98] [99] Inventilated model lung by use of a metered haled steroids may be used in bronchodose inhaler and intratracheal catheter, [86] [87] [88] with pulmonary dysplasia 100 and there has been deliveries in excess of 90% of the dose, much of recent interest in delivery of pulmonary antiit in particles smaller than 5 m. A subsequent oxidants by nebulisation to prevent neonatal report 89 which described epithelial airway le-lung injury. 101 Delivery of surfactant and pulsions in rabbits treated by this method means monary vasodilators directly to the lung raises that it cannot be recommended and emphasises exciting possibilities for the treatment of neothe need for drug delivery methods to be fully natal lung disease. However, little is known of evaluated.
the effect of inhaled medication on the imAn alternative to nebuliser therapy is the use mature lung, and concern has been expressed of a metered dose inhaler and in-line spacer. about the possible effects of high dose sterThese are effective in improving drug delivery oids 102 and of propellants and surfactants in to intubated patients and may be cheaper. 90 metered dose inhalers. 103 The spacer allows high velocity particles from Many of the factors affecting lung deposition the metered dose inhaler to decelerate and discussed in previous sections also apply to propellants to evaporate, reducing particle size. neonates, but very little pertinent clinical inThis reduces impaction of drug on the tubing formation is available. Many of the questions and improves drug delivery. Spacer size is im-posed by a 1990 review 102 remain unanswered. portant 79 but the optimum size is not known.
Once again, spacer devices may prove to be Grigg and colleagues 91 evaluated the delivery more efficient and cheaper than nebulisers. 103 of sodium cromoglycate to ventilated neonates via either an ultrasonic nebuliser or a metered dose inhaler with spacer. They first instilled a known amount of drug into the trachea and  Bronchiolitis is the commonest lower resmeasured the fraction excreted in the urine over the ensuing 24 hours. They then administered piratory tract infection of infancy, 104 occurring in winter epidemics each year. The illness gensodium cromoglycate by one of the two systems studied and, by measuring the urinary ex-erally runs a benign course and, although many infants need admission to hospital, the morcretion, extrapolated the dose delivered to the lungs. Despite a 2-3 fold variation in dose tality is less than 1% of these.
Ribavirin may be used in the treatment of delivered between the infants within each group, the metered dose inhaler and spacer acute bronchiolitis and is administered by a small particle aerosol generator (SPAG) which delivered a much higher dose/kg than the nebuliser (234 g/kg vs 107 g/kg). In a parallel produces particles of drug approximately 1.3 m in diameter. In infants who were prestudy this group compared their in vivo findings with different in vitro methods of measuring viously well, symptom scores and oxygen saturation improved more rapidly in those treated drug delivery from ventilators and found good agreement with a filter and test lung, suggesting with the drug, but the length of time in hospital was unchanged. 105 106 There is no evidence that that this may be the method of choice for further in vitro work in this field. treatment alters long term morbidity. Because of the generally benign course of the illness, A similar proportion of the nominal dose was delivered to the lungs in studies by O'Cal-and the costs and difficulties of ribavirin administration, it is not usually used for infants laghan 92 using beclomethasone in rabbit studies and in vitro by Everard 93 using sodium cromo-who were previously well. 104 Infants with chronic cardiorespiratory disglycate. With a 4 × 11 cm cylindrical chamber connected to the inspiratory limb of the ease such as bronchopulmonary dysplasia are at risk of more severe disease and the mortality ventilator circuit, Everard 93 found better delivery at higher tidal volumes, with longer in-may be up to 3.5% of those who are admitted to hospital. 107 There have been few satisfactory spiratory times, by connecting the spacer as close as possible to the endotracheal tube, and controlled studies of ribavirin therapy in this group. It may improve symptom scores and by actuating the metered dose inhaler immediately before the start of the inspiratory oxygenation, but not mortality or the length of hospital stay.
There have been a number of uncontrolled and signs of respiratory distress. Nebulised racemic adrenaline has been shown to improve reports of ribavirin use in infants mechanically ventilated for bronchiolitis caused by res-respiratory distress transiently. 121 The effect is noticeable within 30 minutes and usually lasts piratory syncytial virus 109 but only two published randomised controlled trials. Smith et less than two hours. There is no evidence that the use of adrenaline alters the natural history al 111 studied 28 infants of mean age 1.4 months, seven of whom had underlying disease. They of the illness, but its use may lead to a decreased need for intubation. 122 Its major use is in chilreceived either ribavirin (20 mg/ml) or sterile water from a SPAG continuously for seven dren in whom temporary relief is required while facilities are arranged to provide an artificial days or until extubated. Those who received ribavirin had significantly shorter duration of airway. In certain patients where it is very important to avoid endotracheal intubationmechanical ventilation, use of supplemental oxygen, and hospital stay. This study has been that is, those with subglottic stenosis -nebulised adrenaline has been given at regular incriticised because of the use of nebulised water as a "placebo" 111 which may have provoked tervals, but only in the intensive care unit where facilities for intubation are immediately availbronchoconstriction, although this has been discounted. 112 113 Furthermore, the duration of able. It should not be used in ambulatory patients who are sent home soon after treatventilation in the placebo group was similar to that of untreated historical controls in a pre-ment. 123 Treatment of croup with systemic corticovious study. 114 Meert et al 115 randomised 41 children who steroids has been investigated extensively and a meta-analysis of 10 studies concluded that required mechanical ventilation for bronchiolitis caused by respiratory syncytial virus this treatment was effective. 124 Husby et al 125 reported that nebulised budesonide (2 ml of to receive either ribavirin 20 mg/ml via a SPAG made up with 0.9% saline or 0.9% saline alone. 500 g/ml using a Pari nebuliser with a CR 60 compressor) given twice, 30 minutes apart, Ribavirin or placebo were given for 18 hours a day for five days or until extubation, whichever resulted in a significant decrease in stridor, cough, recession, dyspnoea, and cyanosis two was sooner. There was no statistically significant difference between the two groups in hours after administration in children with moderate to severe croup compared with a the duration of mechanical ventilation, use of supplemental oxygen, and hospital stay.
control group given nebulised saline. The authors suggest that the rapid onset of action Ribavirin may precipitate in ventilator circuits causing high expiratory pressures and may be due to adrenergic vasoconstriction.
Unfortunately, there were no data on the conleading to pneumothoraces. 116 Blockage of the expiratory valve of the ventilator can be avoided dition of patients following the measurements made two hours after drug delivery, and further by the use of filters in the expiratory limb of the circuit which should be changed regularly. 117 It information is awaited. is currently administered for 12-20 hours per day from a SPAG which releases aerosol into an oxygen tent or hood. High dose therapy of short duration has been shown to reduce the Vaccination Blockage of replication of the measles virus viral load and was well tolerated in one small uncontrolled study. 118 Short duration therapy, in vivo by maternal antibodies may render immunisation ineffective in a number of if efficacious, would allow improved care of infants and should be further evaluated.
very young children. In this age group administration of the vaccine by aerosol has the Nebulised bronchodilators 119 and ipratropium bromide 120 have been used in a number theoretical advantage that antibodies lining the respiratory epithelium, predominantly IgA, are of studies with little effect on measures of illness severity or lung function in infants with acute less likely to be acquired from the mother (and therefore inhibit viral replication and imbronchiolitis, and nebulised salbutamol may worsen oxygen saturation. 20 munisation) than circulating maternally derived antibodies which are predominantly IgG.
In a Mexican study 126 86% of a group of infants aged five months seroconverted after   Nebuliser therapy has made a significant con-immunisation by aerosol with the EdmonstonZagreb strain vaccine. The vaccine was given tribution to the management of children with cystic fibrosis, delivering antibiotics, anti-in-via a nebuliser chamber driven by a compressor for 30 seconds. In a subsequent study in flammatory agents, and bronchodilators to the lungs. Newer treatments to improve sputum Gambia 127 94% of infants aged 4-6 months seroconverted after Edmonston-Zagreb strain clearance are being developed, and the role of nebulisers in this disease is discussed by Spen-vaccine was given by nebulisation into a plastic hood placed over the head and shoulders. cer on pp S89-91.
Measles infection is probably acquired through the nasal or conjunctival mucosa, and this may also be the preferred site of delivery of the  () Croup is common in infants and young children vaccine. This is another example where the optimum site for aerosol delivery is not known. due to acute obstruction of the laryngeal area, usually secondary to a parainfluenza virus in-It is not known if vaccine given by aerosol provides protection earlier than if given by the fection. The clinical syndrome consists of inspiratory stridor, a barking cough, hoarseness, subcutaneous route. In the authors' opinion, nebulisers are overused 
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Conclusions
